Yao, Y., Xu, X
This condition, mainly caused by bacterial infections, oxidative stress, alcohol or chronic allergen exposure, and dysbiosis, leads to the development of several pathologic conditions, including obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver cirrhosis, neurodegeneration, cardiovascular diseases, inflammatory bowel disease, celiac disease, irritable bowel syndrome, type 1 diabetes mellitus (T1D), and several autoimmune conditions (Fig
Food presence reduces gastric pH and increases intestinal transit time, both of which impair this active transport mechanism and reduce drug absorption by up to 40-50%
In OASIS-4, nearly three-quarters of participants on semaglutide experienced gastrointestinal (GI) side effectsmostly nausea and vomitingcompared to about 42% in the placebo group
Current terms for each are posted on their own sites
The difficulty often comes from persistent hunger, cravings, emotional eating, or slow metabolic response that makes it difficult to maintain progress long term